Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Les journées caribéennes des maladies rares et orphelines 2022.
Bellance R, Antolín Sanféliz I, Duclos S, Guiget-Valard AG, Inamo J, Signaté A, Allard-Saint-Albin O, Cantacouzéne M, Garófalo Gómez N, Sarrazin E. Bellance R, et al. Among authors: inamo j. Med Sci (Paris). 2023 Nov;39 Hors série n° 1:67-71. doi: 10.1051/medsci/2023138. Epub 2023 Nov 17. Med Sci (Paris). 2023. PMID: 37975776 Free article. French. No abstract available.
Patients with transthyretin amyloidosis enrolled in THAOS between 2018 and 2021 continue to experience substantial diagnostic delay.
Coelho T, Dispenzieri A, Grogan M, Conceição I, Waddington-Cruz M, Kristen AV, Wixner J, Diemberger I, Gonzalez-Moreno J, Maurer MS, Planté-Bordeneuve V, Garcia-Pavia P, Tournev I, Gonzalez-Costello J, Cariou E, González-Duarte A, Glass O, Chapman D, Amass L; THAOS investigators. Coelho T, et al. Amyloid. 2023 Dec;30(4):445-448. doi: 10.1080/13506129.2023.2229484. Epub 2023 Jul 17. Amyloid. 2023. PMID: 37459334 No abstract available.
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS).
Gentile L, Diemberger I, Plante-Bordeneuve V, Mazzeo A, Dori A, Luigetti M, Di Paolantonio A, Dispenzieri A, Grogan M, Waddington Cruz M, Adams D, Inamo J, Kristen AV, Lino Cirami C, Chapman D, Gupta P, Glass O, Amass L. Gentile L, et al. Among authors: inamo j. PLoS One. 2024 Jan 19;19(1):e0292435. doi: 10.1371/journal.pone.0292435. eCollection 2024. PLoS One. 2024. PMID: 38241252 Free PMC article.
Clinical outcomes for 2788 patients with transthyretin amyloidosis: Tafamidis meglumine early access program in France.
Lairez O, Réant P, Inamo J, Jeanneteau J, Bauer F, Habib G, Eicher JC, Lequeux B, Legallois D, Josse C, Hippocrate A, Bartoli M, Dubois M, Noirot Cosson C, Squara PA, Fievez S, Quinault A, Rudant J, Kharoubi M, Damy T. Lairez O, et al. Among authors: inamo j. Arch Cardiovasc Dis. 2024 Oct 5:S1875-2136(24)00323-1. doi: 10.1016/j.acvd.2024.08.006. Online ahead of print. Arch Cardiovasc Dis. 2024. PMID: 39426850
Inadvertent novel access to the left ventricle through the membranous septum.
Müssigbrodt A, Cabrera JA, Alfie A, Vergier R, Inamo J. Müssigbrodt A, et al. Among authors: inamo j. J Interv Card Electrophysiol. 2024 Aug;67(5):1279-1281. doi: 10.1007/s10840-023-01730-6. Epub 2024 Jan 6. J Interv Card Electrophysiol. 2024. PMID: 38182967 No abstract available.
Infant congenital heart disease prevalence and mortality in French Guiana: a population-based study.
Lucron H, Brard M, d'Orazio J, Long L, Lambert V, Zedong-Assountsa S, Le Harivel de Gonneville A, Ahounkeng P, Tuttle S, Stamatelatou M, Grierson R, Inamo J, Cuttone F, Elenga N, Bonnet D, Banydeen R. Lucron H, et al. Among authors: inamo j. Lancet Reg Health Am. 2023 Dec 14;29:100649. doi: 10.1016/j.lana.2023.100649. eCollection 2024 Jan. Lancet Reg Health Am. 2023. PMID: 38124997 Free PMC article.
121 results